Form 8-K - Current report:
SEC Accession No. 0001493152-25-000247
Filing Date
2025-01-03
Accepted
2025-01-03 16:15:23
Documents
29
Period of Report
2025-01-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39167
2 ex99-1.htm EX-99.1 12034
3 ex99-1_001.jpg GRAPHIC 388283
4 ex99-1_002.jpg GRAPHIC 380833
5 ex99-1_003.jpg GRAPHIC 476549
6 ex99-1_004.jpg GRAPHIC 343746
7 ex99-1_005.jpg GRAPHIC 361747
8 ex99-1_006.jpg GRAPHIC 378351
9 ex99-1_007.jpg GRAPHIC 300736
10 ex99-1_008.jpg GRAPHIC 165739
11 ex99-1_009.jpg GRAPHIC 263256
12 ex99-1_010.jpg GRAPHIC 392110
13 ex99-1_011.jpg GRAPHIC 423917
14 ex99-1_012.jpg GRAPHIC 273203
15 ex99-1_013.jpg GRAPHIC 288337
16 ex99-1_014.jpg GRAPHIC 370551
17 ex99-1_015.jpg GRAPHIC 239014
  Complete submission text file 0001493152-25-000247.txt   7181045

Data Files

Seq Description Document Type Size
18 XBRL SCHEMA FILE envb-20250103.xsd EX-101.SCH 3012
19 XBRL LABEL FILE envb-20250103_lab.xml EX-101.LAB 34240
20 XBRL PRESENTATION FILE envb-20250103_pre.xml EX-101.PRE 24163
31 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3827
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 25506395
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)